View in EDS HTML Full Text PDF Full Text

Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).

Saved in:
Bibliographic Details
Title: Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
Authors: Hochster HS; Rutgers Cancer Institute, New Brunswick, NJ, USA., Catalano P; ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Weitz M; ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA, USA., Cohen D; Mt Sinai Hospital, New York, NY, USA., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA., Faller BA; Missouri Baptist Medical Center Heartland NCORP, St Louis, MO, USA., Kortmansky JS; Yale Cancer Center, New Haven, CT, USA., O'Hara MH; University of Pennsylvania, Philadelphia, PA, USA., Kricher SM; Northwestern University, Chicago, IL, USA., Lacy J; Yale Cancer Center, New Haven, CT, USA., Lenz HJ; Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Verma U; University of Texas, Southwestern Medical Center, Dallas, TX, USA., Benson AB; Northwestern University, Chicago, IL, USA.
Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Sep 01; Vol. 116 (9), pp. 1487-1494.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38775718
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hochster+HS%22">Hochster HS</searchLink>; Rutgers Cancer Institute, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Catalano+P%22">Catalano P</searchLink>; ECOG-ACRIN Biostatistics Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Weitz+M%22">Weitz M</searchLink>; ECOG-ACRIN Biostatistics Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mitchell+EP%22">Mitchell EP</searchLink>; Thomas Jefferson University Hospital, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+D%22">Cohen D</searchLink>; Mt Sinai Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22O'Dwyer+PJ%22">O'Dwyer PJ</searchLink>; University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Faller+BA%22">Faller BA</searchLink>; Missouri Baptist Medical Center Heartland NCORP, St Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Kortmansky+JS%22">Kortmansky JS</searchLink>; Yale Cancer Center, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22O'Hara+MH%22">O'Hara MH</searchLink>; University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kricher+SM%22">Kricher SM</searchLink>; Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Lacy+J%22">Lacy J</searchLink>; Yale Cancer Center, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Lenz+HJ%22">Lenz HJ</searchLink>; Norris Comprehensive Cancer Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Verma+U%22">Verma U</searchLink>; University of Texas, Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Benson+AB%22">Benson AB</searchLink>; Northwestern University, Chicago, IL, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227503089%22">Journal of the National Cancer Institute</searchLink> [J Natl Cancer Inst] 2024 Sep 01; Vol. 116 (9), pp. 1487-1494.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7503089 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278874%22">00278874 </searchLink><i>NLM ISO Abbreviation: </i>J Natl Cancer Inst <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38775718
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jnci/djae114
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1487
    Titles:
      – TitleFull: Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hochster HS
      – PersonEntity:
          Name:
            NameFull: Catalano P
      – PersonEntity:
          Name:
            NameFull: Weitz M
      – PersonEntity:
          Name:
            NameFull: Mitchell EP
      – PersonEntity:
          Name:
            NameFull: Cohen D
      – PersonEntity:
          Name:
            NameFull: O'Dwyer PJ
      – PersonEntity:
          Name:
            NameFull: Faller BA
      – PersonEntity:
          Name:
            NameFull: Kortmansky JS
      – PersonEntity:
          Name:
            NameFull: O'Hara MH
      – PersonEntity:
          Name:
            NameFull: Kricher SM
      – PersonEntity:
          Name:
            NameFull: Lacy J
      – PersonEntity:
          Name:
            NameFull: Lenz HJ
      – PersonEntity:
          Name:
            NameFull: Verma U
      – PersonEntity:
          Name:
            NameFull: Benson AB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1460-2105
          Numbering:
            – Type: volume
              Value: 116
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Journal of the National Cancer Institute
              Type: main
ResultId 1